
FDA approval cancer drug boosts Genmab’s stock by 4% today.
Daewoong Pharmaceutical plant opens in Incheon, showcasing advanced biologics technology and innovation for the pharmaceutical industry.
FDA approval bone disorder brings hope for patients with rare lesions.